Low FOXA1 expression predicts good response to neo-adjuvant chemotherapy resulting in good outcomes for luminal HER2-negative breast cancer casesYoshiya Horimoto(Tokyo Medical University), Mitsue Saito(Juntendo University)British Journal of CancerNovember 25, 201410.1038/bjc.2014.595Cited by 44SaveCiteExport RISWatch citationsRelated Papers2023 MASCC and ESMO guideline update for the prevention of chemotherapy- and radiotherapy-induced nausea and vomiting|ESMO Open|2024|141